SCHEMBL7300286

SCHEMBL7300286

Nc1c[nH]c2ccccc2c1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 3/20 0.50
ALDH1A1 P00352 2/20 0.50
POLB P06746 2/20 0.50
TDP1 Q9NUW8 2/20 0.50
KDM4E B2RXH2 1/20 0.50
LMNA P02545 1/20 0.50
GLA P06280 1/20 0.50
GAA P10253 1/20 0.50
HPGD P15428 1/20 0.50
HTT P42858 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
GFER P55789 1/20 0.49
PRKD3 O94806 1/20 0.47
CCNB2 O95067 1/20 0.47
CCNE2 O96020 1/20 0.47
ABL1 P00519 1/20 0.47
PRKCG P05129 1/20 0.47
PRKCB P05771 1/20 0.47
CDK1 P06493 1/20 0.47
PIM1 P11309 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL37668 0.82 GFER (0.60) ATMALDH1A1TDP1KDM4ESMN1; SMN2
Hydrochloric Acid SCHEMBL23704203 0.80 GFER (0.58) ATMALDH1A1TDP1KDM4ESMN1; SMN2
Iodide SCHEMBL2316312 0.80 GFER (0.58) ATMALDH1A1TDP1KDM4ESMN1; SMN2
SCHEMBL28110454 0.80 GFER (0.58) ATMALDH1A1TDP1KDM4ESMN1; SMN2
Bromide SCHEMBL28737265 0.80 GFER (0.58) ATMALDH1A1TDP1KDM4ESMN1; SMN2
SCHEMBL8079562 0.76 GFER (0.50) ATMALDH1A1TDP1GFERPRKD3
SCHEMBL20258216 0.75 ATM (0.50) ATMALDH1A1POLBTDP1KDM4E
SCHEMBL17048751 0.75 ATM (0.50) ATMALDH1A1POLBTDP1KDM4E
SCHEMBL1072588 0.75 ATM (0.50) ATMALDH1A1POLBTDP1KDM4E
SCHEMBL2747487 0.75 GPR84 (0.52) ATMALDH1A1TDP1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1991013061-A1 4(1H)QUINOLONE DERIVATIVES LABORATORIOS ALMIRALL, SA (ES) 1991-09-05 WO claimed
EP-0445062-A1 4(1H)Quinolone derivatives LABORATORIOS ALMIRALL SA (ES) 1991-09-04 EP claimed
US-20220127266-A1 MALIC ENZYME INHIBITORS SUN PHARMA ADVANCED RESEARCH COMPANY LTD (IN) 2022-04-28 US disclosed
WO-1991013061-A1 4(1H)QUINOLONE DERIVATIVES LABORATORIOS ALMIRALL, SA (ES) 1991-09-05 WO disclosed
EP-0445062-A1 4(1H)Quinolone derivatives LABORATORIOS ALMIRALL SA (ES) 1991-09-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220127266-A1 MALIC ENZYME INHIBITORS ME1, ME2, ME3 ATM 1727/4885ALDH1A1 144/4885POLB 1806/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.